We are living in an era of unprecedented medical entitlement. Earlier this week, the mainstream press erupted in a chorus of uncritical applause for Neena Nizar, a woman who, through sheer determination, successfully secured a clinical trial for a disease so exceedingly rare that it affects only 30 people worldwide. The narrative being spun is one of triumph. We are supposed to look at this woman, who badgered regulators and researchers until they agreed to test a bespoke pharmaceutical intervention on her incredibly specific genetic anomaly, and see a hero.
I see someone looking for a shortcut.
While the media fawns over her ability to navigate the complex bureaucracy of the FDA, I am left wondering why no one is asking the hard questions. Specifically: did she even try eliminating seed oils first?
As a clinician who has spent the better part of a decade observing the downstream effects of modern lifestyle choices from the sterile vantage point of my home infrared sauna, I am deeply troubled by the precedent this sets. It is abundantly obvious to anyone paying attention that true healing comes from within, not from a hastily assembled cohort of 30 people taking a highly experimental synthetic compound. What the mainstream medical establishment deliberately obscures is that the vast majority of so-called "incurable" conditions are simply the body crying out for a more robust hydration strategy.
I have not personally examined Nizar’s medical charts, nor do I know the name of her disease, because I prefer to treat the holistic terrain rather than the reductionist label. I believe it is a bone issue. However, I can say with absolute confidence that her condition, like all conditions, is strongly associated with a dysregulated gut microbiome. By jumping straight to a multi-million-dollar clinical trial, she is entirely bypassing the critical work of discovering which expensive adaptogenic powders she should be whisking into her matcha.
It is immensely frustrating to watch the scientific community validate this kind of impatience. Just last week, over a restorative lunch of activated walnuts with a leading longevity influencer in Topanga Canyon, we discussed this exact phenomenon. We agreed that the modern patient is entirely too eager to outsource their healing journey to white-coated academics, rather than doing the deep, often uncomfortable work of sitting in a cold plunge pool for exactly three minutes every morning while visualizing cellular repair.
If we allow people to simply demand a clinical trial every time they develop a devastating, one-in-a-billion genetic disorder, where does it end? Will we start developing targeted gene therapies for every single person who feels a bit sluggish after eating non-organic gluten? Will Big Pharma be forced to synthesize a cure for the fact that I sometimes get a slight headache when I am forced to fly commercial?
The focus on "rare diseases" is, frankly, a distraction from the diseases that matter to me.
We are dealing with an ultra-rare progressive skeletal dysplasia that fundamentally alters bone formation, which cannot be managed by positive thinking or dietary tweaks.
I am so glad the NIH finally agrees with me. As Dr. Hembree so bravely points out, we cannot simply manage these things with basic "dietary tweaks"—we must completely overhaul our relationship with the circadian rhythm. It is refreshing to see the federal government acknowledging that positive thinking alone is not enough; one must also purchase a proprietary blend of bio-available magnesium and commit to daily breathwork. I applaud her courage in speaking out against the limitations of mere diet.
Consider the sheer volume of synthetic compounds Nizar will be subjected to during this trial. The protocols undoubtedly call for intravenous medications, completely bypassing the liver's natural detoxification pathways. Has anyone bothered to ask how this will affect her aura? The researchers are so myopically focused on halting the progression of a devastating physical illness that they are entirely ignoring the spiritual cost of pharmaceutical intervention. A true healer would have prescribed a three-day dry fast to starve the mutated cells, followed by an aggressive regimen of oil pulling.
The sheer selfishness of demanding a bespoke clinical trial for just 30 people is staggering when you consider the broader health landscape. There are millions of Americans currently suffering from self-diagnosed adrenal fatigue, a condition the FDA outright refuses to acknowledge, let alone fast-track a drug for. My own followers have to pay entirely out of pocket for my twelve-week cortisol-reset masterclass. Yet Nizar expects the entire scientific apparatus of the United States to grind to a halt just because her skeleton is doing something unusual.
I frequently advise my high-net-worth clients that true empowerment is not found in a laboratory. It is found in taking radical responsibility for your own epigenetic expression. If Nizar had simply dedicated the thousands of hours she spent lobbying researchers into optimizing her sleep hygiene and curating her light exposure, she might have found that her ultra-rare disease was actually just a manifestation of trapped ancestral trauma.
Instead, she has chosen the easy way out. She has chosen to be a pioneer in a groundbreaking medical study that could potentially save the lives of those 30 people, rather than doing the hard, solitary work of experimenting with various obscure roots ordered from unregulated international websites. She has surrendered her autonomy to the scientific method, which, as we all know, is hopelessly biased against intuition.
It is a tragic missed opportunity for personal growth. But for the rest of us, the path forward remains unchanged. Do not wait for a peer-reviewed clinical trial to validate your suffering. Buy a continuous glucose monitor, throw away your conventional deodorant, and remember that you are the ultimate architect of your own wellness.